EUVIMEDEUVIMED entdecken
Crossref

In situ assessment of glomerular C3/C5 convertases indicates ongoing complement activation in IgA nephropathy

Augustin Obrecht, Marie-Sophie Meuleman, Jérôme Olagne, Anne Grunenwald, Sophie Chauvet, Lubka Roumenina iD, Véronique Frémeaux-Bacchi, Sophie Caillard, Anna Duval

Nephrology Dialysis Transplantation · 31.03.2026 · 41 (4) · 715-724

DOI: 10.1093/ndt/gfaf200 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nephrology Dialysis Transplantation, online erschienen am 01.10.2025. Verfasst von Augustin Obrecht und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Dialysis and Transplantation, Strasbourg University Hospitals, Strasbourg, France. Hauptthemen laut MEDLINE: Glomerulonephritis, IGA, Complement Activation, Complement C3-C5 Convertases, Kidney Glomerulus. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Fondation pour la Recherche Médicale.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and hypothesis The complement system contributes to the progression of immunoglobulin A nephropathy (IgAN) and offers promising therapeutic targets currently under investigation. Identifying appropriate candidates for these treatments is now critical. Currently, complement activation in IgAN is assessed using immunostaining of kidney tissues, a method that lacks precision in differentiating ongoing and past complement activation.

Methods

Complement deposition was assessed in diagnostic kidney biopsies from 53 patients with primary IgAN and positive C3c staining. Immunohistochemistry was used to assess glomerular deposition of C4d and C5b-9, while immunofluorescence was employed for C3b/iC3b and C1q. In situ detection of C3 and C5 convertase complexes from the classical/lectin (C4b2b) and alternative (C3bBb) complement pathways was performed on paraffin-embedded kidney biopsies from 33 of these patients using a proximity ligation assay (Duolink®). Biopsies from patients with lupus nephritis and C3 glomerulopathy (C3G) served as positive controls. Convertase signals were quantified using QuPath® Software and correlated with MEST-C score, C5b-9 staining and clinical outcomes.

Results

C3bBb convertases were identified in 20/33 C3c-positive (60.6%) patients, with a median positive area of 15.5 (3.4–24.8) ‰ of the glomerular surface. C4b2b convertases were detected in 22/33 (66.7%) patients, covering a median positive area of 8.3 (4.1–11.8) ‰. Both convertases were present in 13/33 (39.4%) patients, while 4/33 (12.1%) patients had no convertases despite positive C3c staining. Double-negative patients had better renal survival (P = .0387). C3bBb-staining positive area significantly correlated with mesangial C5b-9 deposition intensity (P = .0011). Patients with MEST-C scores E1 and S1 showed greater C3bBb intensity at diagnosis (P = .0251 and P = .0004, respectively).

Conclusion

Our study demonstrates ongoing complement activation in 29/33 (87.9%) C3c-positive IgAN patients. Notably, activation of the alternative pathway correlated with E1 and S1 lesions, C5b-9 deposition and poorer renal survival. In situ convertase detection may help identify patients most likely to benefit from complement-targeted therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glomerulonephritis, IGAComplement ActivationComplement C3-C5 ConvertasesKidney GlomerulusComplement C3HumansMaleFemaleAdultMiddle AgedPrognosisFollow-Up StudiesYoung Adult

Stichwörter der Autor:innen

C3 convertasesIgA nephropathycomplementkidneypathology

Substanzen

Complement C3-C5 ConvertasesComplement C3

Autor:innen und Institutionen

  • Department of Nephrology, Dialysis and Transplantation, Strasbourg University Hospitals, Strasbourg, France.
  • Centre de Recherche des Cordeliers, Institut National de la Santé et de la Recherche Médicale, Sorbonne Université, Inflammation, Complement and Cancer Team, Paris, France.
  • University Hospital Federation (FHU) COMET, Paris, France.
  • Department of Pathology, Strasbourg University Hospitals, Strasbourg, France.
  • Department of Nephrology, Poissy-Saint-Germain Intercommunal Hospital Center, Poissy, France.
  • Department of Nephrology, Georges Pompidou European Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.

ORCID-Profile: Lubka Roumenina

Förderung

  • Fondation pour la Recherche Médicale

Zitieren

APA

Obrecht, A., Meuleman, M. S., Olagne, J., Grunenwald, A., Chauvet, S., Roumenina, L., Frémeaux-Bacchi, V., Caillard, S., & Duval, A. (2026). In situ assessment of glomerular C3/C5 convertases indicates ongoing complement activation in IgA nephropathy. Nephrology Dialysis Transplantation, 41(4), 715-724. https://doi.org/10.1093/ndt/gfaf200

Vancouver

Obrecht A, Meuleman MS, Olagne J, Grunenwald A, Chauvet S, Roumenina L, et al. In situ assessment of glomerular C3/C5 convertases indicates ongoing complement activation in IgA nephropathy. Nephrology Dialysis Transplantation. 2026;41(4):715-724. doi:10.1093/ndt/gfaf200

BibTeX
@article{Obrecht2026,
  author = {Obrecht, Augustin and Meuleman, Marie-Sophie and Olagne, Jérôme and Grunenwald, Anne and Chauvet, Sophie and Roumenina, Lubka and Frémeaux-Bacchi, Véronique and Caillard, Sophie and Duval, Anna},
  title = {In situ assessment of glomerular C3/C5 convertases indicates ongoing complement activation in IgA nephropathy},
  journal = {Nephrology Dialysis Transplantation},
  year = {2026},
  volume = {41},
  number = {4},
  pages = {715--724},
  doi = {10.1093/ndt/gfaf200}
}
Kostenlos starten →